KH 7,
330676-02-3,
C17H15BrN4O2S,
KH7,
2-(1H-benzimidazol-2-ylthio)-N'-[(1E)-(5-bromo-2-hydroxyphenyl)methylene]propanohydrazide,
AC1OBAO2,
AC1O2L4Q,
SCHEMBL12027493,
SCHEMBL15799410,
DTXSID20425675,
HMS3648I20,
1811AH,
AKOS001025989,
AKOS016878041,
KH7, >=98% (HPLC),
HY-103194,
RT-013443,
CS-0025285,
SR-01000946378,
J-019001,
SR-01000946378-1,
(E)-2-(1H-Benzo[d]imidazol-2-ylthio)-N'-(5-bromo-2-hydroxybenzylidene)propanehydrazide,
(+/-)-2-(1H-benzimidazol-2-ylthio)propanoic acid 2-[(5-bromo-2-hydroxyphenyl)methylene]hydrazide,
(E)-2-(1H-Benzo[d]imidazol-2-ylthio)-N inverted exclamation marka-(5-bromo-2-hydroxybenzylidene)propanehydrazide,
(plusmn)-2-(1H-benzimidazol-2-ylthio)propanoicacid2-[(5-bromo-2-hydroxyphenyl)methylene]hydrazide,
2-(1H-benzimidazol-2-ylsulfanyl)-N'-[(3-bromo-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]propanehydrazide,
2-(1H-benzimidazol-2-ylsulfanyl)-N'-[(E)-(3-bromo-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]propanehydrazide,
2-[(1H-Benzimidazol-2-yl)sulfanyl]-N'-[(3-bromo-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]propanehydrazide,
CID6843191,
CID 6843191,
CID11281545,